Pfizer Net Worth 2006-2018 | PFE

Interactive chart of historical net worth (market cap) for Pfizer (PFE) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Pfizer net worth as of February 15, 2019 is $252.4B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $252.401B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $365.894B 16.67
Merck (MRK) United States $215.183B 18.39
Novartis AG (NVS) Switzerland $207.623B 17.66
Eli Lilly (LLY) United States $129.746B 22.03
Novo Nordisk (NVO) Denmark $123.032B 19.90
AbbVie (ABBV) United States $121.616B 10.22
Sanofi (SNY) France $106.719B 13.17
AstraZeneca (AZN) United Kingdom $103.646B 11.83
GlaxoSmithKline (GSK) United Kingdom $102.300B 13.43
Bristol-Myers Squibb (BMY) United States $84.336B 12.98